Enter your login e-mail to the account
Search
Search parameters
Search results
- Chronic subdural haematoma associated with advanced malignant tumor
prof. MUDr. Markéta Hermanová, Ph.D., MUDr. Dušan Hrabovský, doc. MUDr. Radim Jančálek, Ph.D., MUDr. Petr Burkoň, Ph.D., doc. MUDr. Jan Chrastina, Ph.D.
(2/2016, Case reports )
- PARP inhibitors in treating metastatic castration-resistant prostate cancer
MUDr. Igor Richter, Ph.D., doc. MUDr. Josef Dvořák, Ph.D., MUDr. Vladimír Šámal, Ph.D., MUDr. Jiří Bartoš, MBA, MUDr. Sofya Al-Samsam
(3/2023, Review articles )
- Bevacizumab in the treatment of patients with ovarian carcinoma
MUDr. Michaela Kubíčková, MUDr. Jozef Šufliarsky, PhD., MUDr. Štefánia Lišková, MUDr. Tomáš Minárik, PhD., MUDr. Andrej Jurík, MUDr. Tibor Lengyel, PhD., MUDr. Igor Slezák, PhD.
(6/2015, Original articles & case reports ) - Poly (ADP-ribose) polymerase inhibitors in the treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(5/2017, Review articles ) - Comprehensive treatment of epithelial ovarian cancer
MUDr. Tibor Packaň, PhD.
(5/2011, Review articles ) - Review on castrate-resistant prostate carcinoma systemic therapy
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2023, Main topic ) - Efficacy of maintenance therapy with the PARP inhibitor olaparib in platinum-sensitive recurrent ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(3/2024, Case reports ) - The role of PARP inhibitors in the treatment of breast cancer
MUDr. Eliška Volochová, MUDr. Marián Streško, PhD.
(2/2022, Main topic ) - Správa z Best of ASCO® Slovakia 2011
MUDr. Mária Rečková
(1/2012, Events ) - Úvodné slovo
RNDr. Michal Konečný, PhD.
(2/2015, Editorial ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - The role of PARP inhibitors in the treatment of ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(4/2021, Main topic ) - Pancreatic and biliary cancer
MUDr. Filip Kohútek, PhD., MUDr. Tomáš Sedláček, MUDr. Branislav Bystrický, PhD., MPH
(1/2018, Review articles )